Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

3 Mega-Cap Stocks Not Named Nvidia Up More than 40% in 2024

Shares of mega-cap stocks such as Walmart, Meta Platforms, and Eli Lilly have surged over 40% in 2024, outpacing the broader markets by a wide margin.

The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race

The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race

The weight-loss drugs market could be worth up to $144 billion within six years. And a bevy of pharma stocks could get a lift.

Investors Business Daily

Eli Lilly Option Trade Could Return $1,650, If Stock Doesn't Go Haywire

Eli Lilly Option Trade Could Return $1,650, If Stock Doesn't Go Haywire

The idea with the trade is that if Eli Lilly stock remains around 950 for the next few weeks, the sold option will decay faster than the bought option.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Popular weight loss drug is getting cheaper

Eli Lilly will now sell cheaper vials of weight loss drug Zepbound in order to meet increased demand.

Stocks Finish In The Black As Nvidia Results Loom; Walmart Keeps Climbing (Live Coverage)

The S&P 500 and Nasdaq pushed in to positive ground after choppy action. Nvidia stock rose as the AI giant's earnings loom.

Investors Business Daily

Eli Lilly Launches Discount Anti-Obesity Drug

The company claims the Zepbound doses cost 50% less than competing drugs

International Business Times

Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug

Eli Lilly will offer weight-loss drug Zepbound in a new form at roughly half the list price. Eli Lilly stock edged higher.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Tirzepatide Cuts Diabetes Risk By 94% In Prediabetic, Obese Individuals: Trial Results

Tirzepatide Cuts Diabetes Risk By 94% In Prediabetic, Obese Individuals: Trial Results

The three-year trial results revealed that a once-a-week tirzepatide injection for adults who are prediabetic, obese, or overweight reduced their risk of progressing to type 2 diabetes by 94%.

Stocks Finish Lower as Chip and Energy Stocks Decline

Stocks Finish Lower as Chip and Energy Stocks Decline

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.24%. US stocks Tuesday gave up an early advance and posted modest losses. Weakness in...

Eli Lilly Weight-loss Drugs Cut Long-term Diabetes Risk: Study

Eli Lilly Weight-loss Drugs Cut Long-term Diabetes Risk: Study

Weight-loss drugs produced and distributed by Eli Lilly show promising results in cutting long-term diabetes risk.

International Business Times

Eli Lilly, Palo Alto up; Lowe’s down - Midday stock movers

Eli Lilly, Palo Alto up; Lowe’s down - Midday stock movers

Here are the stocks making the biggest market moves today.

Stocks Pressured by Chip Stocks and Diabetes Device Makers

Stocks Pressured by Chip Stocks and Diabetes Device Makers

The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.32%. US stocks today gave up an early advance and turned lower. Weakness in chip...

Stocks Waver as the Market Awaits Clues From the Fed About Interest Rates

Stocks Waver as the Market Awaits Clues From the Fed About Interest Rates

The S&P 500 Index ($SPX ) (SPY ) today is down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.30%. US stocks today are slightly lower this morning, despite a decline in T-note yields....

Stocks See Support from Lower Bond Yields and Positive Corporate News

Stocks See Support from Lower Bond Yields and Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.22%. US stocks today are mostly higher, with the S&P 500 climbing to a 1-month...

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Eli Lilly, An IBD 50 Stock, Nears Record High On Another Weight-Loss Win

Eli Lilly stock rose Tuesday after Lilly's weight-loss drug significantly cut the risk of developing diabetes over three years.

Up 58% YTD, is Eli Lilly Stock Still a Buy?

The pharmaceutical giant has already delivered massive gains this year, but Wall Street analysts have only gotten more bullish on the maker of Mounjaro and Zepbound.

Investors Business Daily

Sell-Offs Didn't Scare Funds Off Amazon Stock, These Others

Amazon, Taiwan Semiconductor and Eli Lilly are working toward buy points as funds load up.

5 'Strong Buy' Stocks That Just Reported Killer Earnings

As the earnings season nears its close, here are five ‘Strong Buy’-rated stocks that delivered exceptional earnings results.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Being Vain Has Its Benefits. Why Eli Lilly And The 'Me-Conomy' Are Here To Stay.

Eli Lilly and Novo Nordisk kicked off the "vanity trade," but the trend could be extending to other industries as well.

Investors Business Daily

Funds Load Up On Costco, Eli Lilly, These Other Stocks

Fund managers have been busy buying amid the ongoing market weakness. Four stocks are near buy points or are building bases.

Analysts reset targets for Eli Lilly shares

Here's what may happen next for the pharma giant's stock price.

Investors Business Daily

Dow Jones Futures Rise, 10 Stocks Near Buy Points With Rally Setting Up; Musk-Trump On Tap

The market hasn't confirmed its rally attempt, but more leaders are stepping up. Check out these AI stocks not named Nvidia.

Midday movers: Expedia, Sweetgreen, Eli Lilly up; Nvidia, Intel down

Here are the stocks making the biggest market moves today.

Investors Business Daily

Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review

Monday's global sell-off turned into a stock market rally attempt. Palantir, Eli Lilly and Fortinet were among the earnings winners.

Eli Lilly Stock: Analyst Estimates & Ratings

Eli Lilly has significantly outperformed the broader market over the past year, and Wall Street analysts are bullish about the stock’s prospects.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

249,152 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play